Literature DB >> 14597215

IgM and IgG autoantibodies from microscopic polyangiitis patients but not those with other small- and medium-sized vessel vasculitides recognize multiple endothelial cell antigens.

Youri Chanseaud1, Paloma García de la Peña-Lefebvre, Philippe Guilpain, Alfred Mahr, Mathieu C Tamby, Michèle Uzan, Loïc Guillevin, Marie Christophe Boissier, Luc Mouthon.   

Abstract

Using a quantitative immunoblotting technique on extracts of macrovascular and microvascular endothelial cells (EC), we analyzed serum IgM and IgG reactivities of patients with active disease fulfilling the ACR and Chapel Hill criteria for the diagnosis of polyarteritis nodosa (PAN) (n = 8), PAN related to hepatitis B virus (HBV) infection (HBV-PAN) (n = 5), Wegener's granulomatosis (n = 6), microscopic polyangiitis (MPA) (n = 18), Churg-Strauss syndrome (n = 8), and patients with chronic HBV infection without PAN (n = 5) and age- and gender-matched healthy individuals (n = 45). MPA patients' IgM bound to 200-, 105-, 80-, 65-, 45-, 35-, and 33-kDa major bands, whereas IgM from controls and other patients bound predominantly to the 65-kDa band in EC extracts. MPA patients' IgG reacted mainly with 105-, 70-, 55-, and 38-kDa protein bands, whereas IgG from controls and other patients did not. Our results provide evidence that IgM and to a lesser degree IgG from MPA patients specifically recognize multiple EC antigens.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14597215     DOI: 10.1016/s1521-6616(03)00170-0

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


  8 in total

Review 1.  Endothelial cells, antineutrophil cytoplasmic antibodies, and cytokines in the pathogenesis of systemic vasculitis.

Authors:  Maria C Cid; Marta Segarra; Ana García-Martínez; Jose Hernández-Rodríguez
Journal:  Curr Rheumatol Rep       Date:  2004-06       Impact factor: 4.592

Review 2.  Polyarteritis nodosa revisited.

Authors:  Inés Colmegna; José A Maldonado-Cocco
Journal:  Curr Rheumatol Rep       Date:  2005-08       Impact factor: 4.592

3.  Anti-endothelial cell antibodies in idiopathic and systemic sclerosis associated pulmonary arterial hypertension.

Authors:  M C Tamby; Y Chanseaud; M Humbert; J Fermanian; P Guilpain; P Garcia-de-la-Peña-Lefebvre; S Brunet; A Servettaz; B Weill; G Simonneau; L Guillevin; M C Boissier; L Mouthon
Journal:  Thorax       Date:  2005-09       Impact factor: 9.139

4.  Radical oxygen species production induced by advanced oxidation protein products predicts clinical evolution and response to treatment in systemic sclerosis.

Authors:  A Servettaz; P Guilpain; C Goulvestre; C Chéreau; C Hercend; C Nicco; L Guillevin; B Weill; L Mouthon; F Batteux
Journal:  Ann Rheum Dis       Date:  2007-03-15       Impact factor: 19.103

Review 5.  Antiendothelial cells autoantibodies in vasculitis-associated systemic diseases.

Authors:  Philippe Guilpain; Luc Mouthon
Journal:  Clin Rev Allergy Immunol       Date:  2008-10       Impact factor: 8.667

6.  Identification of target antigens of anti-endothelial cell and anti-vascular smooth muscle cell antibodies in patients with giant cell arteritis: a proteomic approach.

Authors:  Alexis Régent; Hanadi Dib; Kim H Ly; Christian Agard; Mathieu C Tamby; Nicolas Tamas; Babette Weksler; Christian Federici; Cédric Broussard; Loïc Guillevin; Luc Mouthon
Journal:  Arthritis Res Ther       Date:  2011-06-28       Impact factor: 5.156

7.  IgG from patients with systemic sclerosis bind to DNA antitopoisomerase 1 in normal human fibroblasts extracts.

Authors:  Mathieu C Tamby; Amélie Servettaz; Nicolas Tamas; Joseph Reinbolt; Frédéric Caux; Olivier Meyer; Yannick Allanore; André Kahan; Loïc Guillevin; Luc Mouthon
Journal:  Biologics       Date:  2008-09

8.  Choroidal vascularity index as a biomarker of systemic inflammation in childhood Polyarteritis Nodosa and adenosine deaminase-2 deficiency.

Authors:  Ata Baytaroğlu; Sibel Kadayifçilar; Abdullah Ağin; Özge Deliktaş; Selcan Demir; Yelda Bilginer; Jale Karakaya; Seza Özen; Bora Eldem
Journal:  Pediatr Rheumatol Online J       Date:  2020-04-03       Impact factor: 3.054

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.